SMVZX
Price
$12.65
Change
-$0.08 (-0.63%)
Updated
Aug 15 closing price
Net Assets
1.1B
VMVAX
Price
$88.08
Change
-$0.33 (-0.37%)
Updated
Aug 15 closing price
Net Assets
31.04B
Interact to see
Advertisement

SMVZX vs VMVAX

Header iconSMVZX vs VMVAX Comparison
Open Charts SMVZX vs VMVAXBanner chart's image
Virtus Ceredex Mid-Cap Value Equity R6
Price$12.65
Change-$0.08 (-0.63%)
VolumeN/A
Net Assets1.1B
Vanguard Mid-Cap Value Index Admiral
Price$88.08
Change-$0.33 (-0.37%)
VolumeN/A
Net Assets31.04B
SMVZX vs VMVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SMVZX vs. VMVAX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVZX is a Buy and VMVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 31B vs. SMVZX (1.1B). VMVAX pays higher dividends than SMVZX: VMVAX (2.22) vs SMVZX (1.13). SMVZX was incepted earlier than VMVAX: SMVZX (11 years) vs VMVAX (14 years). SMVZX (0.88) is less costly to investors than VMVAX (0.07). SMVZX is a more actively managed with annual turnover of: 141.00 vs. VMVAX (19.00). VMVAX has a lower initial minimum investment than SMVZX: VMVAX (3000) vs SMVZX (2500000). VMVAX annual gain was more profitable for investors over the last year : 7.67 vs. SMVZX (0.47). VMVAX return over 5 years is better than : 65.15 vs. SMVZX (24.20).
SMVZXVMVAXSMVZX / VMVAX
Total Expense Ratio0.790.071,129%
Annual Report Gross Expense Ratio0.880.071,257%
Fund Existence11 years14 years-
Gain YTD4.8055.19892%
Front LoadN/AN/A-
Min. Initial Investment2500000300083,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B31B4%
Annual Yield % from dividends1.132.2251%
Returns for 1 year0.477.676%
Returns for 3 years13.2017.5175%
Returns for 5 years24.2065.1537%
Returns for 10 years5.2687.876%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTHP0.280.02
+8.35%
Guided Therapeutics, Inc.
DSEEY7.760.14
+1.90%
Daiwa Securities Group, Inc.
FBSFF18.00N/A
N/A
Fabasoft AG
CWPS26.76N/A
N/A
Conwest Associates, L.P.
KSRYY7.82-0.28
-3.52%
Kose Corp.